<DOC>
	<DOCNO>NCT02194595</DOCNO>
	<brief_summary>Type 2 diabetes mellitus chronic metabolic disorder characterize progressive deterioration function pancreatic beta-cells , cell produce secrete insulin ( hormone primarily responsible handle glucose body ) . The investigator propose randomize controlled trial determine whether combine basal insulin new medication call exenatide therapeutic strategy preserve beta-cell function early course type 2 diabetes .</brief_summary>
	<brief_title>Preserving Beta-cell Function Type 2 Diabetes With Exenatide Insulin ( PREVAIL )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>1 . Men woman age 30 80 year inclusive 2 . T2DM diagnose physician ≤7 year prior enrolment 3 . Negative antiglutamic acid decarboxylase ( antiGAD ) antibodies 4 . On 02 antidiabetic medication , change dose/regimen precede 4 week 5 . A1c screen 5.5 % 9.0 % inclusive antidiabetic medication , 6.0 % 9.5 % inclusive oral antidiabetic medication 6 . BMI ≥ 23 kg/m2 7 . Negative pregnancy test recruitment woman childbearing potential 1 . Current antidiabetic treatment insulin glucagonlike peptide1 ( GLP1 ) agonist 2 . Type 1 diabetes secondary form diabetes 3 . History hypoglycemia unawareness severe hypoglycemia require assistance 4 . Hypersensitivity insulin , exenatide , formulation product 5 . Renal dysfunction evidence estimate glomerular filtration rate ( eGFR ) &lt; 30 ml/min Modification Diet Renal Disease ( MDRD ) formula 6 . History pancreatitis 7 . Family personal history Multiple Endocrine Neoplasia type 2 ( MEN2 ) familial medullary thyroid carcinoma ( MTC ) 8 . Personal history nonfamilial medullary thyroid carcinoma ( MTC ) 9 . Malignant neoplasm require chemotherapy , surgery , radiation palliative therapy within previous 5 year ( exception basal cell skin cancer ) 10 . Unwillingness perform capillary glucose monitoring least 4 time day treatment 11 . Pregnancy unwillingness use reliable contraception . Women plan pregnancy duration study first 3 month study . Reliable contraception include birth control pill , intrauterine device , abstinence , tubal ligation , partner vasectomy , condom spermicide . 12 . Any factor likely limit adherence protocol , opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>beta-cell function</keyword>
	<keyword>GLP-1</keyword>
	<keyword>insulin</keyword>
</DOC>